U.S. Electronic Equipment and Components Stock News

NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron (ITRI) Quarterly Profit Drop Tests Optimistic Earnings Quality Narrative

Itron (ITRI) opened 2026 with Q1 revenue of US$587 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$2.35 billion and EPS of US$6.37 that frame the latest quarter within a solid run of reported profitability. Over recent periods, the company has seen quarterly revenue track between US$572 million and US$613 million and basic EPS range from US$1.29 to US$2.25. Trailing net income and EPS have moved from US$239 million and US$5.27 a year earlier to US$289 million...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth’s Serra Verde Deal Reshapes Scale Valuation And Growth Prospects

USA Rare Earth (NasdaqGM:USAR) agreed to acquire Serra Verde Group in a transaction valued at about US$2.8b. The deal brings the Pela Ema mine in Brazil and a fully integrated mine and processing hub under USAR’s control. The acquisition includes a 15-year offtake agreement with price floors and new financing commitments. The transaction is positioned to expand USAR’s scale, supply chain security outside Asia, and production capabilities. For investors tracking rare earths, USA Rare Earth...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

Positive REZZAYO Phase III Prophylaxis Data Might Change The Case For Investing In CorMedix (CRMD)

In April 2026, Mundipharma and Melinta Therapeutics, a wholly owned subsidiary of CorMedix, reported positive Phase III topline results from the global ReSPECT trial, showing once-weekly REZZAYO prophylaxis was non-inferior to standard regimens for preventing invasive fungal diseases in adults undergoing allogeneic stem cell transplants, with a favorable safety profile. This outcome strengthens the case for a potential REZZAYO label expansion in a high-risk transplant setting where long-term...
NYSE:CNX
NYSE:CNXOil and Gas

Is It Too Late To Reassess CNX Resources (CNX) After Its Strong Multi‑Year Share Price Run?

If you are asking whether CNX Resources at around US$39 per share still offers value or is starting to look expensive, the next sections will walk through what the current valuation actually reflects. The stock has returned 3.4% over the past week, moved by 3.5% over the last month, is up 7.4% year to date, and has returned 32.6% over the past year and 164.1% over three years. These shifts can change how the market is pricing future expectations and risk. Recent coverage has focused on CNX...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Returns To Q1 Profitability EPS Rebound Tests Bearish Margin Narratives

Centene (CNC) has opened 2026 with Q1 revenue of US$49.9b and basic EPS of US$3.13, setting a clear marker after a volatile run of quarterly earnings. Over recent periods, revenue has moved from US$43.3b in Q1 2025 to US$45.1b in Q4 2025 and now US$49.9b in Q1 2026. Basic EPS has swung from US$2.64 to losses of US$0.51, US$13.50 and US$2.24 per share before returning to a profit of US$3.13 per share in the latest quarter. For investors, that combination of large revenue, sharp EPS swings and...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

3 High Quality Undervalued Stocks With Cash Flow And Margin Upside Potential

With inflation expectations lifting, central banks still signaling tight policy and energy prices adding fresh uncertainty, investors are again paying close attention to quality and resilience. The High Quality Undervalued Stocks screener focuses on companies with strong cash generation and solid balance sheets that the market may be mispricing. That combination can help you stay grounded when yields are shifting and growth signals are mixed across regions. In this article, you will see 3...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Holdings ZBH Q1 Net Margin Compression Tests Bullish Robotics Narrative

Zimmer Biomet Holdings (ZBH) opened Q1 2026 with revenue of US$2.1b and basic EPS of US$1.22, while trailing twelve month EPS stood at US$3.86 on revenue of US$8.4b. Over recent quarters, revenue has moved from US$1.9b in Q1 2025 to US$2.1b in Q1 2026. Basic EPS shifted from US$0.92 to US$1.22 across the same periods, setting up a quarter where compressed net margins are front and center for investors parsing the quality of the result. See our full analysis for Zimmer Biomet Holdings. With...
NYSE:NI
NYSE:NIIntegrated Utilities

A Look At NiSource (NI) Valuation As Recent Share Price Momentum Draws Attention

Why NiSource (NI) Is Back on Investor Radar NiSource (NI), a regulated natural gas and electric utility serving several Midwestern and Mid Atlantic states, has drawn fresh attention as its shares show solid gains over the past month and past 3 months. See our latest analysis for NiSource. The recent 1 month share price return of 5.5% and 3 month share price return of 9.4%, alongside a 1 year total shareholder return of 25.5% and 5 year total shareholder return of 119.0%, point to momentum...
NYSE:SPOT
NYSE:SPOTEntertainment

Spotify Technology NYSE SPOT Net Margin Surge Tests Bullish Profitability Narratives

Spotify Technology (SPOT) opened 2026 with Q1 revenue of €4.5b and basic EPS of €3.50, alongside trailing twelve month revenue of €17.5b and EPS of €13.16 that sit against a year where earnings grew 132.2% and the net profit margin moved from 7.2% to 15.4%. Over recent quarters, revenue has stepped up from €4.2b in Q4 2024 to around €4.5b in Q1 2026, while quarterly basic EPS has ranged from €1.81 in Q4 2024 to €5.71 in Q4 2025 before landing at €3.50 in the latest period. Taken together,...
NYSE:ASB
NYSE:ASBBanks

Assessing Whether Associated Banc-Corp (ASB) Looks Undervalued After Recent Share Performance And Profitability Signals

Assessing recent performance and valuation signals Without a specific news headline triggering today’s move, Associated Banc-Corp (ASB) still offers several fresh data points that matter for shareholders, from recent share price performance to reported profitability and valuation signals. The stock’s total return sits at 0.2% over the past day, 0.9% over the past week, about 13% over the past month, and roughly 5% over the past 3 months. These figures provide multiple short-term reference...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Is It Time To Reassess Baidu (BIDU) After Its Recent Share Price Rebound?

Wondering if Baidu at around US$125.76 is giving you enough value for the risk you are taking, or if the market has already priced in most of the story? The stock has delivered a 2.0% return over the past week and 18.0% over the last month, while year to date it is down 16.3% and up 43.2% over the past year. It has a 7.8% return over 3 years and a 35.7% decline over 5 years. These mixed returns come against a backdrop of ongoing interest in large Chinese tech names and evolving sentiment...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Assessing Qfin Holdings (QFIN) Valuation After Recent Share Price Recovery Signs

Qfin Holdings (NasdaqGS:QFIN) has been drawing attention after a stretch of weak share performance, with the stock down over the past year despite positive one month returns and a recent close of $12.97. See our latest analysis for Qfin Holdings. The recent 1 month share price return of 1.57% has not reversed the weaker trend. The 3 month share price return stands at 19.29% and the year to date share price return at 31.92%, while the 1 year total shareholder return is 65.22%. If Qfin’s recent...
NYSE:PFSI
NYSE:PFSIDiversified Financial

Is PennyMac Financial Services (PFSI) Offering Value After A 30% Year To Date Pullback?

Wondering if PennyMac Financial Services at around US$91.18 is a bargain or a value trap? This article walks you through what the current price might be implying. The stock has returned 0.6% over the last 7 days and 6.7% over the last 30 days. Yet year to date it is down 30.7% and sits 3.9% lower over 1 year, which can catch the eye of investors looking for a possible reset in expectations. Recent coverage has focused on PennyMac Financial Services as part of broader discussions about US...
NYSE:EPC
NYSE:EPCPersonal Products

Is It Time To Reassess Edgewell Personal Care (EPC) After Its Volatile Share Performance?

If you are wondering whether Edgewell Personal Care at around US$22.79 is a bargain or a value trap, it helps to break the story into recent returns, business context, and what the numbers actually say about price versus value. The stock has had a mixed run, with a 1.3% decline over the last 7 days, an 8.4% gain over 30 days, a 35.2% gain year to date, a 24.1% decline over the past year, a 45.3% decline over 3 years, and a 37.1% decline over 5 years. Recent attention on Edgewell Personal...
NYSE:UP
NYSE:UPAirlines

A Look At Wheels Up Experience (UP) Valuation As Shares Struggle And Losses Persist

Why Wheels Up Experience Stock Is On Investors’ Radar Wheels Up Experience (UP) has drawn attention after a prolonged share price slide, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. See our latest analysis for Wheels Up Experience. At a share price of US$6.16, Wheels Up Experience has seen weak momentum recently, with a 30 day share price return showing a 28.88% decline and a 1 year total shareholder return showing a 68.74% loss,...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

WesBanco Names New Chief Risk Officer As Governance Priorities Evolve

WesBanco (NasdaqGS:WSBC) has appointed Nathan Jones as Senior Executive Vice President and Chief Risk Officer. Jones succeeds longtime executive Mike Perkins, who is retiring after more than thirty years with the company. The transition reflects a leadership change in a core risk function that is central to WesBanco's banking operations. For a regional bank like WesBanco, risk management sits at the heart of how it runs its balance sheet, sets credit standards, and structures its lending...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

Amkor Technology (AMKR) Margin Improvement To 6.2% Tests Bearish Profitability Narratives

Q1 2026 earnings snapshot Amkor Technology (AMKR) opened 2026 with Q1 revenue of US$1.7b and basic EPS of US$0.34, alongside trailing twelve month revenue of US$7.1b and EPS of US$1.76 that frame the latest quarter in a broader earnings context. Over the past year, the company has seen revenue move from US$6.3b to US$7.1b on a trailing basis, while quarterly EPS stepped up from US$0.09 in Q1 2025 to US$0.34 in Q1 2026, indicating a different earnings run rate than a year ago. With net profit...
NasdaqGM:FRBA
NasdaqGM:FRBABanks

First Bank (FRBA) Q1 Non Performing Loan Spike Tests Bullish Margin Improvement Narrative

First Bank (FRBA) opened Q1 2026 with total revenue of about US$30.8 million and basic EPS of roughly US$0.31, setting the tone for how its earnings power is holding up. Over the past year, revenue on a trailing twelve month basis has moved from around US$128.2 million to about US$133.6 million, with EPS over the same window running between roughly US$1.56 and US$1.75, giving investors a clearer read on how the top line is feeding into per share results. With a net profit margin near the low...
NYSE:BRO
NYSE:BROInsurance

Brown And Brown (BRO) Margin Compression Challenges Bullish Earnings Growth Narrative In Q1 2026

Brown & Brown (BRO) kicked off Q1 2026 with total revenue of US$1.9 billion and basic EPS of US$1.27, alongside trailing twelve month figures of US$6.3 billion in revenue and US$3.53 in EPS that frame the latest quarter in a bigger context. Over recent periods, revenue has moved from US$1.2 billion in Q4 2024 to US$1.6 billion in Q4 2025 and US$1.9 billion in Q1 2026. Quarterly basic EPS has shifted from US$0.73 to US$0.78 and now US$1.27, setting up a story where investors will be weighing...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Assessing Leonardo DRS (DRS) Valuation After Recent Share Price Weakness

Why Leonardo DRS (DRS) is on investors’ radar Leonardo DRS (DRS) has drawn attention after a period where the stock showed a 1-day return of a 1.3% decline and a past-week return of a 7% decline, prompting fresh interest in its recent performance profile. See our latest analysis for Leonardo DRS. The recent 1 month share price return of a 10.4% decline at a share price of US$40.18 sits against a 15.5% year to date share price gain and a 3 year total shareholder return of about 171%. This...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Mondelez Shareholder Votes Test Board Independence And Plastics Oversight Priorities

Mondelez International (NasdaqGS:MDLZ) shareholders are set to vote at the 2026 annual meeting on a proposal calling for an independent board chairman. A separate proposal asks for an objective evaluation of the company’s plastics packaging practices and related policies. The board has recommended that shareholders vote against both proposals, signaling its stance on current governance and sustainability frameworks. Mondelez International, the snacks and confectionery group behind brands...
NasdaqGS:FELE
NasdaqGS:FELEMachinery

Franklin Electric (FELE) One Off Loss And 6.9% Margin Test Bullish Growth Narrative

Franklin Electric (FELE) has opened 2026 with Q1 revenue of US$500.4 million and basic EPS of US$0.77, alongside trailing twelve month revenue of about US$2.2 billion and EPS of US$3.36 that frame the latest quarter in a broader context. Over the past year, quarterly revenue has ranged from US$455.2 million to US$587.4 million, while basic EPS has moved between US$0.37 and US$1.32, setting a clear reference point for how this new print fits into the recent run rate. With a trailing net margin...
NasdaqCM:AXGN
NasdaqCM:AXGNMedical Equipment

Axogen (AXGN) Q1 Loss Of US$0.38 EPS Tests Bullish Margin Improvement Narrative

Axogen (AXGN) opened 2026 with Q1 revenue of US$61.5 million and a basic EPS loss of US$0.38, alongside a net loss of US$19.6 million. This keeps the focus firmly on how fast the top line can support a path back toward profitability. Over the past five reported quarters, revenue has moved from US$48.6 million in Q1 2025 to US$61.5 million in Q1 2026, while basic EPS has swung between a small profit of US$0.02 and losses, including US$0.08 in Q1 2025 and US$0.38 this quarter. In that context,...
NYSE:SHW
NYSE:SHWChemicals

Sherwin-Williams (SHW) Net Margin Compression Tests Bullish Earnings Growth Narratives

Sherwin-Williams (SHW) opened 2026 with Q1 revenue of US$5.7b and basic EPS of US$2.18, alongside net income of US$534.7m, setting the tone for how investors will read the rest of the year’s earnings story. The company’s quarterly revenue moved from US$5.3b in Q1 2025 and US$5.3b in Q4 2024 to US$5.7b in Q1 2026, while basic EPS shifted over the same periods from US$2.02 to US$1.92 and now US$2.18. This puts the focus squarely on how consistently Sherwin-Williams converts this top line into...